DI MATTEO, Francesca
 Distribuzione geografica
Continente #
AS - Asia 320
EU - Europa 239
NA - Nord America 90
SA - Sud America 47
AF - Africa 2
OC - Oceania 1
Totale 699
Nazione #
SG - Singapore 255
IT - Italia 139
US - Stati Uniti d'America 82
BR - Brasile 43
RU - Federazione Russa 39
HK - Hong Kong 28
DE - Germania 26
CN - Cina 23
IE - Irlanda 8
AT - Austria 7
IN - India 6
MX - Messico 6
NL - Olanda 6
BE - Belgio 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
FI - Finlandia 2
FR - Francia 2
GB - Regno Unito 2
UA - Ucraina 2
AR - Argentina 1
CA - Canada 1
CL - Cile 1
EC - Ecuador 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
KI - Kiribati 1
NG - Nigeria 1
NP - Nepal 1
PK - Pakistan 1
PY - Paraguay 1
SE - Svezia 1
TN - Tunisia 1
TR - Turchia 1
VN - Vietnam 1
Totale 699
Città #
Hong Kong 28
Singapore 24
Chandler 15
Munich 15
Afragola 14
Naples 14
Fisciano 13
Ashburn 12
Beijing 10
Salerno 9
Dublin 8
Sarno 8
Moscow 7
Nuremberg 7
Cava de' Tirreni 5
Orvieto 5
Somma Vesuviana 4
São Paulo 4
Vienna 4
West Jordan 4
Belo Horizonte 3
Frankfurt am Main 3
New Delhi 3
Pellezzano 3
Princeton 3
Agropoli 2
Bangor 2
Bolzano 2
Brno 2
Cadoneghe 2
Cerignola 2
Itaguara 2
Los Angeles 2
Pescara 2
Rome 2
Uccle 2
Abingdon 1
Acerra 1
Almè 1
Alto Alegre do Maranhão 1
Alvorada 1
Amman 1
Amsterdam 1
Araraquara 1
Asunción 1
Baronissi 1
Bologna 1
Brasília 1
Brussels 1
Campagna 1
Campinas 1
Cascavel 1
Catalão 1
Columbus 1
Comeana 1
Concepción 1
Cotia 1
Cuiabá 1
Dallas 1
Dhaka 1
Dnipro 1
Esmeraldas 1
Fresno 1
Guarujá 1
Guaíra 1
Helsinki 1
Honolulu 1
Horizonte 1
Iaciara 1
Inhumas 1
Islamabad 1
Itajaí 1
Itapemirim 1
Jaguariúna 1
João Pessoa 1
Kathmandu 1
Lagos 1
Lappeenranta 1
Lucknow 1
Mandeville 1
Miami 1
Milan 1
Milford 1
Milwaukee 1
Monteforte Cilento 1
Montmorency 1
Mumbai 1
Myrhorod 1
Niterói 1
Nola 1
Norfolk 1
Nova Iguaçu 1
Padova 1
Paulista 1
Petrolina 1
Pindobaçu 1
Pompei 1
Pontecagnano 1
Pozzuoli 1
Pune 1
Totale 311
Nome #
Targeting the CXCR4/CXCL12 Axis in Cancer Therapy: Analysis of Recent Advances in the Development of Potential Anticancer Agents 200
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization 143
A Comprehensive In Vitro Characterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors 43
Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization 43
KCNT1 Channel Blockers: A Medicinal Chemistry Perspective 40
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis 40
Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2 39
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization 39
Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone 33
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models 29
Novel para‐phenylenediamine‐based derivatives as Receptor Tyrosine Kinase‐like Orphan Receptor 1 (ROR1) Inhibitors: An in vitro preliminary characterization 25
Voltage-Gated K+ Channel Modulation by Marine Toxins: Pharmacological Innovations and Therapeutic Opportunities 24
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel 23
Totale 721
Categoria #
all - tutte 2.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 0 2 9 0 1 1 1 2 1 2
2022/202354 1 7 1 11 4 9 0 5 5 2 3 6
2023/202475 5 4 4 1 2 16 4 6 11 10 2 10
2024/2025556 23 5 23 24 24 32 67 21 35 22 133 147
2025/202617 17 0 0 0 0 0 0 0 0 0 0 0
Totale 721